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Abstract
Background: Exposure to secondhand smoke (SHS) in the antenatal and postnatal period is associated with a
detrimental health impact to the foetus and newborn baby and is recognised as a preventable public health
challenge. The aim of the mother’s learning about secondhand smoke (MLASS) study was to test the feasibility
of delivering and evaluating the effectiveness of a smoke-free homes (SFH) health education intervention in the
antenatal and postnatal period to reduce foetal and newborn exposure to SHS.
Methods: Pregnant women aged 17–40 years old who attended their first community-based antenatal
appointment in Leeds, UK, were eligible to participate if they currently smoked, or if they were non-smokers but
lived in a household where someone else smoked, or had regular visitors to the home who smoked. A SFH health
education intervention was delivered at four time points by community midwives and health visitors. Outcome
measures included self-reported level of household smoking restrictions and SHS exposure in pregnant women
who did not smoke during pregnancy and in the newborn baby, measured by salivary and urine cotinine levels,
respectively. We planned to conduct focus group discussions with participants and health professionals. A post
hoc survey of pregnant women was conducted at the recruitment site.
Results: Eight pregnant women were recruited over a 6-month recruitment period. Of the 65 eligible pregnant
women approached, 57 (88 %) declined to participate in the study. The majority declined to participate due to lack
of interest in the study. In the post hoc survey, the majority of pregnant women reported that they were already
implementing household smoking restrictions to reduce SHS; only a small number had no household smoking
restrictions.
Conclusions: The post hoc survey identified women who could benefit from a SFH intervention; therefore, future
studies should consider what SFH means to pregnant women and may wish to target those not currently
implementing household smoking restrictions. Future recruitment strategies in studies of an SFH intervention
in the context of maternity service pressures needs careful consideration; this includes the capacity to undertake
the research, the recruitment setting, the criteria for individuals requiring the intervention, and individuals’
willingness to engage with such research.
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Background
Smoking in pregnancy is a leading preventable cause of
foetal, obstetric and neonatal morbidity and mortality
associated with numerous adverse outcomes including
poor foetal intra-uterine growth and neuro-development,
placental abruption, miscarriage, preterm birth and low
birth weight [1]. Likewise, exposure to secondhand smoke
(SHS) in the antenatal and in postnatal period is associ-
ated with a detrimental impact to the foetus and newborn
baby and is recognised as a preventable public health
challenge [2].
SHS is the inhalation of other people’s tobacco smoke
commonly known as ‘passive smoking’; other terms in-
clude ‘environmental tobacco smoke’ and ‘involuntary
smoking’ [3]. There are two types of SHS, ‘side stream’
smoke from the burning tip of a cigarette and exhaled
‘mainstream’ smoke exhaled by the smoker [4]. Toxins
inhaled in both mainstream and side stream smoke are
substantial. Over 4000 chemicals (both particles and
gases) including chemical irritants and almost 70 car-
cinogens are inhaled in mainstream smoke by smokers
[5]. Whilst side stream has a similar composition to
mainstream smoke, the concentrations of toxins and
carcinogens in side stream smoke have been found to
be substantially higher [6].
Prevalence of self-reported SHS exposure during preg-
nancy in a large UK cohort study has been estimated as
13 % [7] and in low- and middle-income countries be-
tween 9.3 and 82.9 % [8]. In the UK, approximately 50 %
of all newborns are exposed to tobacco smoke due to
maternal smoking or contact with SHS [7]. Globally, an
estimated 700 million children, almost half of the world’s
child population, are thought to be exposed to SHS [9].
Women’s exposure to SHS during pregnancy reduces
infants’ adjusted mean birth weights by on average 36 g
and increases the risks of babies being small for gesta-
tional age or low birth weight at term [7]. Newborns
and infants exposed to SHS after birth are also at
increased risk of acute lower respiratory infections,
middle ear infections, SIDS, meningococcal disease, de-
veloping and exacerbating asthma, increased frequency
of hospital visits, persisting wheeze and reduced lung
function [10].
Although legislation to ban smoking in enclosed public
places and workplaces has been adopted in several coun-
tries, including the UK since 2007 [11–13], the majority
of SHS exposure experienced by pregnant women and
children including newborns occurs at home [13, 14].
Pregnancy and parenthood has been identified as a life
event that can influence health-related beliefs, attitudes
and behaviours, particularly as early pregnancy and par-
enthood offer the opportunity for health education inter-
ventions when there is heightened awareness of health
risks to the pregnant woman, unborn foetus and newborn
baby [15]. Recognition of the potential risks to a child’s
health has been identified as a major determinant of
families agreeing to implement smoking restrictions
[16]. It has been suggested that developing parents’
confidence in providing a smoke free environment and
offering to support them in achieving this goal is likely
to be effective [17].
However, the evidence to support specific measures to
implement smoking restrictions and reduce SHS expos-
ure at home in the antenatal and neonatal period is lim-
ited due to lack of research using objective outcomes
measurements, theory-driven interventions and appro-
priate settings to offer SHS-related advice [18, 19].
A recent systematic review evaluated five randomised
controlled trials (RCT) that compared usual care with
psychosocial interventions to assess reduction in SHS
exposure in non-smoking pregnant women, including
one also offering cessation support (pharmacological) for
smoking partners [20]. However, the poor study quality
of three trials due to lack of biochemical validation
using cotinine levels of self-reported exposure to SHS
limit recommendations regarding the effectiveness of
one intervention over another.
An additional limitation of studies that have evaluated
strategies to reduce SHS exposure in antenatal and post-
natal periods that have reported objective biochemical
outcome measures is that only a very small minority as-
sess both maternal and infant cotinine levels to evaluate
SHS exposure.
In the UK, promoting smoke-free homes is a national
priority as highlighted in several policy documents in-
cluding ‘Beyond Smoking Kills’ [21], ‘Passive Smoking
and Children’ [22] and NICE guidance on smoking and
pregnancy [23]. More recently, a report by the World
Health Organisation strongly recommended that routine
screening should be undertaken for SHS exposure in
pregnant women attending routine antenatal care, and
interventions should be targeted at pregnant women to
reduce the exposure to SHS in pregnancy [24].
We developed a smoke-free homes (SFH) intervention
in consultation with pregnant women, new mothers and
health professionals designed to help pregnant women
and new mothers learn about the hazards of SHS, evalu-
ate their own smoking behaviour and empower them to
negotiate smoking restrictions at home. The mother’s
learning about secondhand smoke (MLASS) study aim
was to test the feasibility of delivering and evaluating the
effectiveness of a SFH health education intervention with
(i) non-smoking pregnant women to reduce their expos-
ure to SHS in the home and reduce foetal exposure to
SHS and (ii) with new mothers (irrespective of their smok-
ing status) to reduce newborn babies exposure to SHS in
the home. In addition, we conducted a brief post hoc sur-
vey in another group of pregnant women to identify the
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extent to which they received smoke-free homes informa-
tion from their community midwife and implement smok-
ing restrictions in their homes.
Methods
We planned to test out the feasibility of the interven-
tion and its evaluation by piloting it with women and
their newborns using a quasi-experimental mixed
methods approach consisting of two elements, a quan-
titative before-and-after study and a qualitative study in
order to (i) test its fidelity, appropriateness and accept-
ability, (ii) investigate the key constraints and drivers in
delivering a SFH intervention and (iii) optimise param-
eters (e.g. recruitment, outcomes measurements) to
strengthen the design of a future trial.
Figure 1 displays a summary of the study pathway, and
this includes details of participant recruitment and the
time points for data collection and delivery of the SFH
intervention.
Quantitative study
Participants and setting
Pregnant women aged 17–40 years old were eligible to
participate if (i) they currently smoked or (ii) if they were
non-smokers who lived in a household where someone
else smoked (e.g. partner, parent or other family member)
or had regular visitors to the home who smoked and (iii)
they resided among two deprived localities with a higher
than average prevalence of household smoking in Leeds,
UK. Women were excluded from the study if they did not
Fig. 1 MLASS study pathway
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smoke and did not live in a smoking household. No other
study exclusion criteria were imposed.
In the UK, most maternity care is provided by the
National Health Service (NHS) where 96.7 % of women
access and book their maternity care via their general
practitioner or community midwife team [25]. In the
NHS, the majority of antenatal care is provided by com-
munity midwives and postnatal care provided by commu-
nity midwives for the first 10 days after delivery and then
by community health visitors. The two localities chosen as
the research sites are representative of the NHS maternity
services landscape as they are served by community
midwifery teams that deliver antenatal maternity care
at community health centres (CHCs) and provide post-
natal maternity care between 1 and 7 days postdelivery
in both the home and CHCs, and health visiting teams
delivering child and family health services in the home
and at CHCs from 28 weeks pregnancy through to the
child’s fifth year.
Intervention
In the phase 1 developmental stage of the project, devel-
opment of the intervention was based on behaviour
change techniques included in a 26-item taxonomy [26]
developed from behaviour change theories such as Social
Cognitive Theory, Theory of Planned Behaviour and
Theory of Reasoned Action. According to Abraham and
Michie (2007) [26], the taxonomy provides a pre-defined
set of distinct, theory-linked definitions of behaviour
change techniques (BCTs) so theories that specify the
same process of behaviour change imply the same BCT,
and therefore, use of the taxonomy supplements inter-
vention description by providing a list of BCTs and the
accompanying theoretical underpinning and not just a
description of the mode of intervention delivery and
type of person delivering the intervention component.
The taxonomy provides a theoretical framework to de-
scribe the intervention components, and Abraham and
Michie acknowledge that further work is required to
translate theories relevant to behaviour change into spe-
cific change techniques [26]. The taxonomy has since
been updated [27].
In the phase 1 stage, two of the authors (HT and BR)
mapped proposed intervention components to the
abovementioned 26-item taxonomy [26]. Additional file
1 displays the mapping exercise and demonstrates which
of the BCTs were mapped to proposed potential activ-
ities and techniques in order to describe each compo-
nent included in the intervention, as recommended by
Abraham and Michie [26].
The intervention was further developed during con-
sultation with over 100 pregnant women and new
mothers attending child health centres in Leeds, UK,
and 16 health professionals from midwifery and health
visiting services between September 2011 and January
2012. Focus group discussions were conducted with
women to elicit current knowledge about the hazards
of SHS and their views about the content and delivery
of the intervention. Separate focus groups were con-
ducted with health professionals regarding the content
and delivery of the intervention. Emergent themes from
focus groups with women were investigated in a semi-
structured questionnaire; health professionals also com-
pleted a version of this questionnaire. Details of focus
group discussion topic guides and questionnaires are
presented in Additional file 2.
The key elements that emerged from the consultations
with the new mothers and health professionals identified
that the intervention needed to be delivered in routine
care and at different time points during the antenatal
and postnatal period, with both midwives and health vis-
itors involved in the delivery and that women required
support on how to influence smokers in the family to
reduce newborn exposure to SHS and also factual infor-
mation about the harms and consequences of SHS
exposure.
The phase 1 consultation process resulted in the cre-
ation of a health education intervention to be delivered by
community midwifery services and health visitor services
at three or four time points (dependent on smoking sta-
tus) during pregnancy and in the first ten postnatal days
after delivery.
The study intervention comprised:
Intervention A: a heat-sensitive (images only appear on
touch), educational leaflet which can be used in
interactive sessions to be inserted into the pregnant
woman’s maternity notes. This intervention is focused
on supporting the woman to avoid SHS during pregnancy
in order to protect the developing foetus. Activating the
heat-sensitive component was designed to reveal a hidden
message to ‘imitate’ the action of clearing away a cloud of
smoke and provoke a cognitive reaction among pregnant
women to act and protect their foetus from secondhand
smoke.
Intervention B: an educational leaflet focused on raising
awareness of the harms of secondhand smoke and ways
to protect the newborn baby from secondhand smoke
after birth.
Intervention C: a magnetic concertina credit card-sized
piece of print that the woman can give away to family
and friends to ask them not to smoke around the new-
born baby.
Intervention D: an educational booklet written from the
perspective of the baby telling a story of welcoming the
baby into the home. The intervention is aimed at
supporting the new mother in reinforcing smoke-free
homes messages.
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A copy of each intervention is displayed in Additional
file 3.
Women received SFH information from their com-
munity midwife and health visitor at routine antenatal
and postnatal appointments. SFH information was
delivered at four time points between 16 weeks of
pregnancy and 10 days after the baby was born. Com-
munity midwives were responsible for delivering inter-
ventions A and C, and health visitors were responsible
for delivering interventions B and D. The intervention
delivery involved the health professional giving the
woman the educational resource and a brief conversa-
tion signposting her to the information it contained.
Timing of the intervention delivery and the service re-
sponsible for delivery of each intervention was based
on advice from the midwifery and health visiting ser-
vices that agreed to host the research sites. Timings of
intervention delivery and choice of service were based
on each service identifying key maternity care contact
points during routine care with women across the
antenatal and postnatal care pathway where it would
be feasible to deliver the educational resources in
routine practice. The key contact points identified
were at:
 16 weeks pregnancy; all women attend an
appointment with their community midwife after
confirmation of their pregnancy via the first
ultrasound scan. This appointment was therefore
the earliest opportunity to deliver the first
intervention (intervention A) to protect the
pregnant mother from SHS exposure and the
unborn foetus.
 28 weeks pregnancy; all women receive a routine
‘Early start’ contact with health visiting services. The
routine contact is designed to introduce the new
mother to the service and discuss the mother and
future baby’s well-being and the overall family health
and circumstances; therefore, this key contact was
ideal to deliver the second intervention focused on
protecting the newborn baby when born from SHS
exposure.
 third postnatal day; when all women receive a
routine visit from their community midwife and this
represented the earliest postnatal opportunity to
deliver a third intervention (intervention C) to
remind the new mother about the harms of SHS
exposure to the newborn baby.
 tenth postnatal day; when all women receive a
routine home visit from their health visitor and this
contact represented the next earliest opportunity in
routine practice to deliver a fourth intervention
(intervention D) to re-inforce the smoke-free homes
message in the early postnatal period.
Measures
The primary outcome measure was exposure to SHS.
This was measured in two ways:
Antenatal primary outcome measure
The primary antenatal outcome was measured in
pregnant women who did not smoke during pregnancy
(but living with a partner who smokes and/or have
regular visitors to the house who smoke) was salivary
cotinine levels. Saliva samples were collected at study
entry (baseline) and at 28–32 weeks gestation. Saliva
samples were collected using a Sarstedt Salivette
(www.sarstedt.com). Non-smoking pregnant women
were asked to place a small dental roll in their mouth
for approximately 3 to 5 min until saturated, which was
then placed in the salivette container. Baseline saliva
samples were collected in the antenatal clinic with the
help of the researcher. Follow-up sample packs were
mailed to participants, who collected the sample and
mailed it directly to the laboratory. Measurement of
secondhand smoke exposure in those women who
smoked in pregnancy was not undertaken—any
measurement of SHS exposure would be irrelevant as
their cotinine levels would confirm they smoked.
Postnatal outcome measure
The primary postnatal outcome, which was measured
in newborn babies, irrespective of their mother’s
smoking status, was urine cotinine levels at three
postnatal time points. Postnatal time points specified
for urine sample collection were between 1–7 postnatal
days, 10–14 postnatal days and 6–8 weeks after baby’s
delivery. Urine samples from newborns were collected
by the new mother at home by use of a urine collection
kit provided by the research team and delivered by the
midwives and health visitors at the time the
intervention was delivered. The method of urine
collection comprised cotton wool balls placed in the
baby’s nappy (diaper) close to the urethra. After the
baby passed urine, the urine-soaked cotton wool balls
were placed inside a 50-ml plastic syringe and the
urine was expressed into a small container. Mothers
were asked to only collect urine samples from ‘clean’
nappies not contaminated with baby’s faeces. A
printed instruction leaflet for the collection of urine
samples was included in each urine collection kit.
Urine samples were posted directly to the laboratory
in a container approved for mailing biological samples.
The saliva and urine samples were analysed by gas-
liquid chromatography technique that can detect cotin-
ine levels as low as 0.1 ng/ml [28]. Cotinine levels de-
tected in non-smoking pregnant women and newborns
indicate SHS exposure. The interpretation of salivary and
urine cotinine levels was based on defined cut points:
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interpretation of pregnant women’s salivary cotinine levels
(ng/ml) <0.1 = no exposure to SHS, 0.1–12 = exposure to
SHS and >12 = smoker [29]. The interpretation of new-
born babies urine cotinine levels (ng/ml) are as follows:
<0.1 = no exposure to SHS, 0.1–50 = exposure to SHS,
and >50 = smoker [30].
Demographic data were collected at baseline, and the
level of smoking restrictions at home was measured
through a self-report survey completed by the women at
baseline, 28–32 weeks of pregnancy and between 6 and
8 postnatal weeks after delivery.
Sample size
We planned to recruit a purposive sample of 200 pregnant
women and their unborn babies. A formal sample size
calculation was not performed; we planned to recruit 200
pregnant women in order to explore the potential target
population and assist with decisions regarding future re-
search work around the target population and interven-
tion delivery parameters.
Recruitment and follow-up procedure
Recruitment was conducted over a 6-month period
from September 2013 to February 2014. Women were
identified as eligible to participate by a community
midwife (CMW) at the time they attended their first
midwifery appointment in a community health centre
to confirm their pregnancy (gestation approximately
6 weeks) and book their maternity care (the ‘booking
visit’). This includes a referral for the first routine ultra-
sound scan (USS) undertaken at approximately 12 weeks
gestation to establish the estimated date of delivery
(EDD). The first USS takes place at either of the two
general hospitals that provide maternity services to the
residents of Leeds, UK, within the Leeds Teaching
Hospitals National Health Service Trust (LTHT). As
part of the booking visit in LTHT, CMWs routinely ask
questions about pregnant women’s and their partners’
smoking status. Pregnant women who were eligible to
participate were informed by the CMW about the
study, given a study information pack and informed
that a researcher would approach them in the antenatal
clinic within the hospital after their first routine ultra-
sound scan to establish the EDD. A study referral form
for eligible women was sent by the CMW to the re-
search midwifery team located at the two general hospi-
tals, in order to identify the date and time of the USS
for each potential participant and inform the researcher
to attend the appointment. After the USS appointment,
the MLASS researcher (RM) approached the potential
participant and enquired if they wished to participate in
the study. For those pregnant women who agreed to
participate written informed consent was obtained by
the researcher (RM); baseline data (demographic data,
self-reported household smoking restrictions and salivary
cotinine of non-smoking pregnant women) was obtained.
At study entry, participants also provided written in-
formed consent on behalf of their unborn babies. Pregnant
women who declined to participate were invited to
complete an anonymous decline form to indicate their
reasons for non-participation. Eligible pregnant women
who declined to participate were asked to endorse as
many reasons as they wished from a pre-defined list of
decline statements. Women who declined could also
complete free text comments about their reason for de-
cline. An additional opportunistic recruitment strategy
was also implemented, whereby all dating scan bookings
at the antenatal clinics for the two study sites were noti-
fied to the researcher (RM) via additional searching of
scan bookings via the NHS booking systems at the recruit-
ment site by the research midwife team at LTHT.
Ethical approval for the study was granted by Yorkshire
and the Humber Research Ethics Committee (Reference:
12/YH/0257).
Analysis
The descriptive characteristics of the study sample using
proportions where required were used to analyse these
data and, if appropriate, bivariate analysis of key vari-
ables were conducted.
Qualitative study
A post-intervention qualitative study was undertaken
with the health professionals who delivered the inter-
vention and the women who received it to elicit their
views on the appropriateness, acceptability and feasi-
bility of the intervention in this setting.
We planned to invite women to a focus group discussion
(FGD) post-intervention. We intended to invite a purpos-
ive sub-sample of 12–14 women based on the following: (i)
socio-demographic characteristics, (ii) women who re-
ceived the intervention antenatally, (iii) women who did
not receive the intervention antenatally, (iv) women from
households that implemented changes in the home to pro-
tect themselves whilst pregnant/protect the newborn, and
(v) women from households that did not implement
changes in the home to protect themselves whilst preg-
nant/protect the newborn. Topics included understanding
to what extent mothers felt supported through the smoke-
free homes intervention, which factors motivated them,
and which were their main constraints.
We planned to invite CMW and HV health profes-
sionals who had delivered the intervention to a separate
FGD. Topics were designed to gain an in-depth under-
standing of the way the intervention was implemented,
which factors acted as barriers to effective implementa-
tion and how health professionals overcame these.
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We planned to record qualitative interviews using a
digital recorder, transcribe interview verbatim, then code
data and analyse these data using thematic analysis. [31].
Post hoc survey method
An anonymous self-report survey was conducted after
MLASS data collection ended with pregnant women who
attended for US scan between April and June 2014 at the
LTHT antenatal clinic in order to identify to what extent
pregnant women (a) already received information about
smoke-free homes from their CMW and (b) implement
smoking restrictions in the home (see Additional file 4).
Pregnant women were invited by the researcher (RM) to
complete the brief anonymous self-report survey. All
pregnant women who attended for US scan were eligible
to complete the survey.
Results
Pregnant women were recruited over a 6-month period be-
tween October 2013 and February 2014. Table 1 displays
the number of pregnant women identified, approached and
recruited from the different recruitment strategies. Over
the 6-month recruitment period, only eight pregnant
women consented to participate in the study. In the first
10 weeks of the recruitment period, only six study eligibil-
ity referrals were sent by the community midwives to the
research team (see Table 1).
Of the 65 eligible women approached, a total of 57
(88 %) pregnant women declined to participate in the
study.
Forty-nine decline forms were received (86 % response
rate) comprising a total of 114 reasons for declining (see
Table 2).
An additional question on the decline form asked eli-
gible pregnant women if they would be more likely to
participate if they were offered a financial incentive. The
following responses were received: ‘No’ = 42 women,
‘Yes’ = 3 women, and ‘Not sure’ = 4 women.
All eight participants, who consented to participate in
the MLASS study, completed the self-report survey at
study entry, which collected demographic data and
household smoking information. The age range of par-
ticipants at study entry (baseline) was 17–30 years of
age; five participants were ≤21 years old. Four partici-
pants reported that they were current smokers and four
were non-smokers who lived with a partner who
smoked or another family member (i.e. parent) who
smoked. All eight participants reported their ethnicity
as white. Two participants were in full-time employ-
ment, two were unemployed and four were students.
Level of education reported by participants comprised
left school at 16 with no qualifications = 1, left school
at 16 with some qualifications = 2, left school at 18 with
some qualifications = 4 and higher education (e.g. Bach-
elor’s degree) = 1.
Table 3 displays the outcomes data the study was able
to collect from the eight participants.
A total of seven participants provided either saliva
samples and/or baby’s urine samples for analysis to de-
termine the presence or absence of cotinine and expos-
ure to SHS. Table 4 displays the results from the
participants who provided samples and an interpretation
of these data. A total of four participants provided sam-
ples of their baby’s urine; however, only one participant
collected three urine samples from her baby as per the
study protocol. The table shows that all four infants
were exposed to SHS.
There were no adverse outcomes, such as miscarriage,
stillbirth or serious hospitalization during the MLASS
study associated with the participant’s pregnancy, at the
time of the baby’s birth or in the 8-week study period
after the baby’s birth. All eight participants delivered
their babies between March and August 2014. Adher-
ence by health professionals to the intervention delivery
schedule is displayed in Additional file 5.
Qualitative study
We intended to conduct an FGD with participants and a
separate FGD with health professionals to find out their
views on the appropriateness, acceptability and feasibility
of the SFH intervention in this setting. Poor overall re-
cruitment meant that an FGD with participants was not
feasible. We sought to undertake face-to-face interviews;
however, only two participants agreed to interview. A
Table 1 Study recruitment
Number of
pregnant women
Total number of study eligibility notification forms
sent by community midwives during 6-month
recruitment period
54
Additional USS bookings identified by antenatal
administration team
178
Total number of pregnant women identified from
research sites during 6-month recruitment period
232
Total number of women approached in antenatal
clinic
131a
Number of pregnant women eligible to
participate
65b
Number of smokers approached 41
Number of eligible non-smokers approached 24
Number of eligible pregnant women declined 57
Number of eligible pregnant women consented 8
a101 pregnant women were not approached by the researcher (63 = researcher
unable to attend; 36 = other reasons, e.g. failed pregnancy; patient did
not attend)
bNon-eligible pregnant women approached = 66 (63 = non-smokers, 2 = failed
pregnancy, 1 =moved from study site area)
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FGD with health professionals was not possible due to
NHS service constraints (reasons included time and
case-load pressures); however, we were able to conduct a
face-to-face interview with one health professional from
each participating service.
Due to the limited data available from the small number
of face-to-face interviews that were conducted, we cannot
draw any transferable conclusions as to the usefulness and
acceptability of the SFH advice to a wider population of
women in other antenatal and postnatal settings or indeed
the capacity of other maternity services and health visiting
services to deliver a SFH intervention in other maternal
and child healthcare service settings.
Post hoc survey results
Given that participant recruitment was so challenging
and only eight pregnant women consented to participate,
a post hoc survey among another group of pregnant
women, after the MLASS study data collection period,
helped us to contextualise our findings.
All 542 pregnant women approached by the re-
searcher (RM) completed the survey. Pregnant women
who completed the survey were 9–39 weeks gestation
(average gestation = 23 weeks); 68 % (368) pregnant
women reported that they did not currently smoke or
lived with a smoker, and 17 % (91) pregnant women re-
ported that they currently smoked. There were a total
of 32 % (174) smoking households comprised of the
following: pregnant women who smoke living with a
non-smoking partner = 14, pregnant women who smoke
living with a smoker/regular visitors of house who
smoke = 77 and non-smoking pregnant women who live
with a partner who smokes/regular visitors to the house
who smoke = 83.
From the 174 smoking households, 80 % (139) preg-
nant women reported that they had received informa-
tion related to SHS from their CMW, 2 % (3) reported
that information was received from another source and
18 % (32) reported that they had not received any such
information. Of the 139 pregnant women who reported
receiving smoke-free homes information from their
CMW, 91 % recalled either receiving the smoking ces-
sation information that forms part of their handheld
maternity notes at the booking visit, receiving NHS
smoking cessation leaflets or receiving verbal advice
from their CMW to refrain from smoking inside the
house. Pregnant women reported the following infor-
mation on smoking restrictions implemented in their
household (see Table 5).
Discussion
The MLASS study sought to examine the feasibility of
delivering a SFH intervention in antenatal and in
Table 2 Eligible pregnant women’s reasons for decline
Reason for decline Number of
responses
I am not interested in taking part in this study 33
I do not want to receive educational information
about smoke free home
9
I do not think smoke free homes is an important issue 3
I do not have time to take part in this study 26
I do not feel well enough to take part in this study 4
I think it would be too much commitment to take
part in this study
20
Other reasons:
Don’t want to give/collect baby urine samples 5
We already have a smoke free home 7
Other reason (n = 3)/family commitments (n = 4) 7
Table 3 Participant outcomes data collection
Participant
smoking status
Saliva samples received 30-week pregnancy F/up
survey received
Baby’s urine samples received after
delivery
6–8-week postnatal F/up
(survey and interview)
Smoker N/A No One sample received 23 PN weeks
after delivery
Lost to F/up
Non-smoker Baseline only No None Lost to F/up
Smoker N/A Yes One sample received dated PN day
14
No survey.Interview completed.
Smoker N/A No None Lost to F/up
Non-smoker Baseline only No None Lost to F/up
Non-smoker Baseline and at
30 weeks gestation
Yes None Survey completed.Declined to
participate in interview.
Non-smoker Baseline and at
30 weeks gestation
Yes Sample 1 received dated PN day
6Sample 2 received dated PN day
12Sample 3 received dated 7 PN
weeks
Survey completed.Interview
completed.
Smoker N/A Yes One sample received 3 PN weeks
after delivery
Lost to F/up
F/up follow-up, PN postnatal
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postnatal period and to examine key uncertainties such
as recruitment and retention, fidelity of the intervention,
appropriateness of outcomes and validity of the research
tools. We found the study extremely challenging due to
difficulties encountered in recruiting participants, pri-
marily due to the lack of interest of eligible pregnant
women in the study. Retention of participants within the
study and collection of outcomes data such as saliva and
urine samples was also difficult.
This feasibility study design included both (i) smoking
and non-smoking pregnant women and (ii) community
midwives (MWs) and health visitors (HVs) for interven-
tion delivery, and (iii) the study was designed to test the
feasibility of delivering an intervention across the ante-
natal and early postnatal pathway. At the time of design-
ing the study, it was not known how many women
would be the optimum number to recruit; therefore, a
precise sample size was not estimated. We did not know
in which part of the maternal care pathway would it be
the optimum to deliver the intervention, whether indeed
the intervention could be delivered by MWs and HVs
and also whether one particular participant group might
be more interested in participating or need/request add-
itional support to implement smoking restrictions in
their home, for example non-smoking pregnant women.
We believed that if we aimed to recruit a sample of 200
pregnant women, we could explore the potential target
population and that a sample of this size would allow us
to make a definitive decision as to how to proceed in
terms of our target population and intervention delivery
parameters if the feasibility study moved forward to a
pilot cluster randomised controlled trial.
Challenges encountered in the study recruitment dem-
onstrated that in the context of the local community
midwifery service, it was not feasible for CMWs to iden-
tify sufficient numbers of eligible pregnant to achieve a
study sample size of 200 pregnant women in the course
of routine community antenatal care appointments.
It was particularly difficult to engage with all of the po-
tential CMWs to participate in the identification of eligible
pregnant women in the context of their routine care of
pregnant women, and in the first 10 weeks of recruitment,
only six eligibility referrals were sent to the research team.
There were fewer numbers of referrals of eligible preg-
nant women received than expected from the CMWs;
therefore, there was a much smaller pool of pregnant
women available for the researcher to approach for
Table 4 Results of salivary samples and urine samples of study participants
Participant
smoking
status
Saliva samples
received from
pregnant women
Saliva
cotinine
result (ng/ml)
Saliva: level of exposure
to secondhand smoke
(SHS)
Baby’s urine samples
received after delivery
Urine
cotinine
result (ng/ml)
Urine: level of exposure
to secondhand smoke
(SHS)
Smoker N/A N/A – One sample received
23 PN weeks after
delivery
20.9 Exposure to SHS
Non-smoker Baseline only 155.3 Smoker None – –
Smoker N/A N/A – One sample received
dated PN day 14
5.5 Exposure to SHS
Non-smoker Baseline only 1.1 Exposure to SHS None – –
Non-smoker Sample 1 at baseline 0.2 No exposure to SHS None – –
Sample 2 at F/up <0.1 No exposure to SHS
Non-smoker Sample 1 at baseline <0.1 No exposure to SHS Urine sample 1
received dated PN
day 6
<0.1 No exposure to SHS
Sample 2 at F/up <0.1 No exposure to SHS Urine sample 2
received dated PN
day 12
<0.1 No exposure to SHS
Urine sample 3
received dated at 7 PN
weeks
1.3 Exposure to SHS
Smoker N/A N/A – One sample received 3
PN weeks after delivery
10.3 Exposure to SHS
F/up follow-up, PN postnatal
Table 5 Household smoking restrictions
Response choices Number of responses
(n = 174)
My home was smoke free even before I found
out I was pregnant
85 (49 %)
My home has been smoke free since I found
out I was pregnant
55 (32 %)
There are no smoking restrictions in my house 31 (18 %)
Additional comments provided:
Smoking is restricted to the kitchen
3 (1.7 %)
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recruitment. Discussions with CMWs about the reasons
for lack of eligibility referrals found that the constraints
and time pressures at the booking visit, which is the
first antenatal care appointment that women have with
their community midwife, meant that it was difficult to
add an additional task, there was lack of motivation
among pregnant women to engage in a study about
SHS, many of the pregnant women approached by
CMWs questioned whether there was any benefit of
taking part in the study and many pregnant women re-
fused to take the study literature when offered.
There were also issues with the opportunistic re-
cruitment strategy. The researcher was unable to as-
certain smoking status prior to the USS appointment,
and therefore, a significant amount of time was wasted
approaching women who did not smoke and did not
live with a smoker; this accounted for a total of 66
women of the 131 women approached who were not
eligible to participate due to their non-smoking status.
In addition, the opportunistic strategy meant that
pregnant women were approached with no prior warn-
ing of the study, so prior to researcher’s approach,
women had no opportunity to consider the research,
which may have affected pregnant women’s willingness
to consider study participation. In addition, our local
comprehensive local research network did not have
any funds available to facilitate recruitment in MLASS
study and despite it being accepted as a National Insti-
tute for Health Research (NIHR) portfolio study—a
status that usually confers assistance with study re-
cruitment and study activities.
The other main factor associated with poor recruit-
ment was the lack of pregnant women’s willingness to
engage with the study; only eight pregnant women con-
sented to participate. The majority of eligible women
who were approached reported that they were not inter-
ested in participating, and the two other most common
reasons for declining were cited as lack of time and too
much commitment expected in the study. Women who
declined to participate indicated that they would be un-
likely to participate in the study even if they were offered
a financial incentive. Of the eight women who consented
to participate, five were lost to study follow-up in the
postnatal period with regard to the follow-up survey and
the face-to-face interview. This is despite antenatal non-
responders receiving three non-response reminders as
necessary, which included one text message reminder, a
follow-up survey and covering letter and a reminder tele-
phone call and postnatal non-responders who received
two text message reminders.
Adherence to the delivery of the SFH intervention by
health professionals was monitored (Additional file 5).
Three out of the four non-smoking pregnant women re-
ceived intervention A as per protocol at approximately
16 weeks of pregnancy. There was excellent adherence
to the delivery of interventions B and D by health visi-
tors; all interventions given by health visitors were deliv-
ered as per specified protocol time points. However,
there were difficulties with adherence to the delivery of
intervention C by CMWs between day 1 and day 7 after
the baby’s birth. Only one participant received the inter-
vention as per protocol, and therefore, it is difficult to
draw any conclusions as to the capacity of the midwif-
ery service to deliver this information. Challenges cited
by CMWs that were identified in poor adherence to the
delivery of intervention C included service constraints
such as time pressure, large caseloads, not all new
mothers are routinely seen on day 3 after delivery, op-
erational difficulties with the weekend service and staff-
ing problems.
Of the eight women that participated, only one non-
smoking participant provided the full complement of
samples required in the study (Table 4)—two saliva sam-
ples in the antenatal period and collection of all three
urine samples from the baby as per the specified time
points within the protocol. Overall, four out of eight par-
ticipants collected a urine sample. This indicates that it
was possible for some new mothers to collect a sample
of baby’s urine by placing cotton wool balls into the
nappy and extruding a sample of urine via a syringe.
However, the lack of samples collected by three of the
participants (only one sample each) indicates that these
new mothers needed support and supervision to collect
their samples. Support to collect samples of urine in
future studies could involve research nurse visits to the
house to help support and collect a sample.
It is difficult to draw any generalisable conclusions
about the potential to recruit in a future study such as
MLASS as the recruitment numbers were so small and
the majority of eligible women approached were not in-
terested in participating in the study.
Anecdotal comments from eligible women and their
partners at the time they were approached by the re-
searcher and asked to participate in the study suggested
that many of the women believed that they already imple-
mented a smoke-free home. Anecdotal comments made
by pregnant women and their partners at the recruitment
site included “We don’t smoke in the house anyway”, “Not
smoking in the house.….it’s common sense isn’t it?” and
“Well, if I don’t smoke in my own house then no-one else
is going to smoke in it either”.
When we conducted a post hoc survey of pregnant
women attending for USS regarding the type of infor-
mation that pregnant women receive from their com-
munity midwife and household smoking restrictions,
we found that the majority of pregnant women living in
a smoking household who completed the survey be-
lieved that they had received SHS-related advice.
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However, when questioned about the type of advice re-
ceived, this turned out to be smoking cessation advice.
It seems fair to speculate that in this sample of preg-
nant women, the concept of receiving information
about ‘smoke-free homes’ appeared to be associated by
the majority of women with any type of information
about smoking cessation advice in general. When preg-
nant women were questioned about household smoking
restrictions, the majority of women reported that they
already had a smoke-free home before their pregnancy
or had implemented smoking restrictions since they
had found out they were pregnant.
A small group of women (18 %) indicated in the post
hoc survey that there were no smoking restrictions in
their house. This indicates that there is a small, poten-
tially hard to reach sub-population of pregnant women
who may benefit from a smoke-free homes intervention
but who either do not want to engage with any type of
smoke-free advice, have not been given any opportunity
to discuss such issues with a health professional or have
not been able to engage their partner or family members
in negotiating smoking restrictions or creating a smoke-
free home. This information is important as women who
report that there are no smoking restrictions in their
house may require targeted identification in any future
studies or in routine healthcare practice, rather than
attempting to target all pregnant women who smoke or
live with a smoker who feel that they will not benefit
from the advice or interventions as they are already
restricting smoking in their home.
The information regarding the number of women who
reported that they already had a smoke-free house either
before pregnancy or since pregnancy appears to corrob-
orate anecdotal comments received by the researcher
(RM) at the time eligible pregnant women (with their
partners) were approached who commented that their
homes were already smoke-free and this may also ac-
count for the lack of interest by pregnant women in a
study that aimed to deliver SFH advice.
However, the findings of the post hoc study have limi-
tations; the post hoc study was based on self-reported
information, and therefore, there is no objective valid-
ation of whether these respondent’s homes were actually
smoke-free. Although respondents may have reported to
the researcher either anecdotally during the recruitment
phase or completing the post hoc survey that they im-
plemented smoking restrictions, we do not know what
being ‘smoke-free’ or having a smoke-free home actu-
ally means to these respondents. In addition, the post
hoc survey sample was different from those that were
approached to participate in the MLASS study, and it is
difficult therefore to generalise the findings of the post
hoc survey to the wider population of pregnant women
who live in smoking households; it is possible that in a
different setting, interest in study participation would
have been different.
Future investigators could consider changes to the re-
cruitment strategy, changes to the timing and delivery
of the intervention and changes to support the women
to provide samples to improve the design and methods
of the study. For example, the recruitment strategy
could be strengthened by the researcher being present
in the community clinics at the time the pregnant
woman attends her appointments with the community
midwife as all pregnant women would have the oppor-
tunity to speak to the research team and consider parti-
cipation—this also avoids approaching non-eligible
women, i.e. approaching non-smoking women and also
would prevent delays in receiving information about
women who may or may not be eligible. In the UK,
women’s handheld maternity notes contain standard
maternity documentation to record their maternity
care. These notes could also contain the first interven-
tion (intervention A) as a matter of usual practice, ra-
ther than an extra task to be undertaken during a
routine appointment. Community midwives would be
able to signpost women to the leaflets during the dis-
cussion about smoking status; this would also facilitate
brief discussions about secondhand smoke and smok-
ing. At post-delivery discharge from the hospital,
women could receive intervention C as part of their
routine discharge information/discharge letter rather
than on the third postnatal day. The midwife respon-
sible for the new mother’s discharge from the hospital
could signpost the new mother to the SHS information
as part of her discharge information. Collection of sal-
iva samples from non-smoking pregnant women could
be improved if a research assistant or midwifery re-
search support worker could collect the samples at the
time the woman attended two routine antenatal ap-
pointments at her local GP practice or child health
clinic. In the UK, all women usually see their CMW at
16 weeks after the USS confirms pregnancy and have
an additional appointment at some point in the third
trimester. Dependent on local arrangements and tim-
ings of appointments, women would therefore be sup-
ported in providing a saliva sample. Collection of urine
samples could be improved if a research assistant or
midwifery research support worker were based in the
CHCs to help women collect the samples. Support to
obtain these could be offered at follow-up postnatal
visits or where child health care takes place and by chan-
ging the postnatal time frame that babies’ urine samples
are collected. As part of routine maternity care, women in
the UK attend a 6-week postnatal check-up with their GP
and are routinely offered the five-in-one infant vaccination
(diphtheria, tetanus, whooping cough, Hib and polio) at 8,
12 and 16 weeks old. In addition, health visitors also
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provide other routine developmental child health clinics,
so there is potential opportunity to obtain a urine sample
at these appointments.
Supporting participants to provide samples in com-
munity clinics would require consideration of capacity
of community clinics to host research staff and add-
itional costs of research staff. An additional consider-
ation is that maternity care pathways (i.e. key contact
points and care delivery settings) will also vary in differ-
ent countries; therefore, researchers will need to liaise
closely with local maternity services and design future
studies that take account of local service configuration
to facilitate intervention delivery.
Future studies might also consider inclusion of screen-
ing questions, such as those used in the post hoc survey
prior to any intervention about current household smok-
ing restrictions in order to target those women who are
not currently willing or able to negotiate and implement
household smoking restrictions. Consideration of what
smoke-free means to pregnant women in order to imple-
ment smoking restrictions as part of a targeted interven-
tion should be undertaken. Therefore, qualitative work
could be conducted prior to future studies to understand
what being smoke-free and a smoke-free home means to
pregnant women, what smoke-free homes advice means
and the relevance of such advice to pregnant women in
early pregnancy.
One of the most challenging aspects of this study was
poor recruitment due to lack of interest in the study;
therefore, future studies should consider how the study
could be designed to be more appealing to pregnant
women. It would be useful to conduct qualitative work
with another sample of pregnant women and new
mothers to obtain feedback on the four interventions
used in this study and provide information as to how
the interventions can be made more appealing. Further-
more, women in this study did not receive feedback
about their cotinine results in pregnancy or the cotin-
ine levels in their baby’s urine. Given that new mothers
wish to protect their baby from harms, this may act as
motivation to participate in a study and help women
identify the level of SHS exposure to their infant.
Conclusions
In conclusion, due to the small number of participants
who participated in the study, it has not been possible
to demonstrate the feasibility of collecting relevant data
required for an evaluation of a SFH intervention and
delivery of a SFH intervention to pregnant women and
women with newborn babies. Future recruitment strat-
egies in studies of SFH interventions in the context of rou-
tine maternity services and community midwifery service
pressures and constraints may need careful consideration
and planning in terms of the service capacity to
undertake the research, the recruitment setting and
method of recruiting pregnant women, the identifica-
tion of the most appropriate person to deliver the inter-
vention (including timing of delivering the
intervention), the criteria for individuals requiring the
intervention and individuals’ willingness to engage with
SFH research.
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